Nasdaq Nordic Nasdaq Stockholm Welcomes Intervacc to First North. Stockholm, April 7, 2017 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Intervacc AB’s shares (short name: IVACC) commenced today on Nasdaq First North in Stockholm. Intervacc belongs to the health care sector and is the 24 th company to be admitted to trading on Nasdaq’s Nordic markets* in 2017.

News feed of Intervacc. Intervacc utvecklar vaccin inom djurhälsovård. 2020-06-16 17:31:00 Intervacc intends to carry out a directed share issue 0,00% | 10

Intervacc: Kallelse till årsstämma i Intervacc AB (publ) Aktieägarna i Intervacc AB (publ), org.nr 556238-1748, kallas härmed till årsstämma torsdagen den 11 juni 2020 klockan 17.00 på Good Morning Hotel, Västertorpsvägen 131, 129 44 Hägers How has Intervacc's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : IVACC is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 7% a week. Information on stock, financials, earnings, subsidiaries, investors, and executives for Intervacc. Use the PitchBook Platform to explore the full profile. Stocks in Play – Intervacc stiger på emission och Josab pressas av ny Kina-strategi. Intervacc.

Intervacc stock

Latest Share Price and Events Stable Share Price : IVACC is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 7% a week. An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Intervacc AB. Over the past six months, the relative strength of its shares against the market has been 85.95%. På denna sida hittar du historiska data för Intervacc AB stock (IVACC) liksom sista betalkursen, öppen, högsta, lägsta,, förändring och förändring i %. Information on stock, financials, earnings, subsidiaries, investors, and executives for Intervacc. Use the PitchBook Platform to explore the full profile.

Intervacc´s main area is to develop modern sub-unit vaccines against economically important bacterial infections, within animal health.

Whether you’re thinking of building up a portfolio to supplement your wage or to make a living out of, you’ll want to buy well and make money. There will be losses along the way, but that’s normal when you’re starting out. Learn quickly and

Feb. 2, 2017 at 9:35 a.m. ET by Tomi Kilgore. Company profile page for Intervacc AB including stock price, company news, press releases, executives, board members, and contact information Intervacc är ett utvecklingsbolag som utvecklar nya vacciner baserade på rekombinanta proteiner för att möta det ökande behovet av effektiv djurhälsa. Marknaden för djurvacciner växer globalt och bolagets förhoppning är att dess teknologiplattform för nästa generations vacciner, skall ger stora möjligheter att ta nya marknadsandelar.

Intervacc är ett svenskt bioteknikföretag som utvecklar nya vacciner mot infektioner inom området djurhälsa. Utvecklingsarbetet baseras på ny teknologi med rekombinanta proteiner istället för avdödande eller försvagade mikroorganismer, vilket finns i konventionella vacciner.

If you are looking for stocks with good return, Intervacc can be a profitable investment option. Intervacc quote is equal to 32.550 SEK at 2021-04-07.

Dozens of bullish and bearish live candlestick chart patterns for the Intervacc AB stock. The primary markets for Intervacc is the EU and USA where the number of horses is estimated to 16 millions (FAOSTAT). Based on the amount of sold vaccine doses in the EU, we estimate that 30-60 % of all horses in these markets are being vaccinated against various infectious diseases. 2021-04-08 · Intevac stock price target raised to $11.50 from $10.00 at B. Riley.
Västerbron (musikgrupp)

View which stocks have been most impacted by COVID-19. What price target have analysts set for IVAC?

#immunovia #intervacc #inventmedic #läkemedel #nanologica #phaseholographic #pledpharma #nasdaqstockholm #redeye #stockmarket #stocks. 11.
Youtube joakim lamotte

romani flag
hur mycket tjanar man som busschauffor
plats rimlexikon
kalevi wiik suomalaisten juuret
medleverturnus ledig stilling
hur mycket sjunker en ny bil i värde
arbete om astrid lindgren

Intervacc är ett svenskt bioteknikföretag som utvecklar nya vacciner mot infektioner inom området djurhälsa. Utvecklingsarbetet baseras på ny teknologi med rekombinanta proteiner istället för avdödande eller försvagade mikroorganismer, vilket finns i konventionella vacciner.

Share. Play Later.

Tre rosor klocka
barnets namn

Affärsvärldens IPO-guide granskar Intervacc notering. På IPO-guiden hittar du Granskar alla noteringar. IPO-guiden sponsras av Spotlight stock market logo.

Get Intervacc stock price history and adjusted historical data with charts, graphs, and statistical analysis. Intervacc is Sweden Stock traded on Stockholm Stock Exchange 9 timmar sedan · Stockholm, April 12, 2021 - Intervacc AB ("Intervacc") announced today that they have entered into an exclusive distribution agreement with Dechra Pharmaceuticals PLC, ("Dechra") to commercialize Intervacc's leading vaccine candidate Strangvac in Europe, excluding the Nordic and Baltic countries where Intervacc will market and sell Strangvac directly. Med bakgrund i forskning vid Karolinska Institutet och Sveriges lantbruksuniversitet, tar Intervacc nu sikte på börsen och listning på Nasdaq First North, via en emission som ska bl.a. ska finansiera de första stora batcherna av den första vaccinkandidaten. Insiders at Intervacc Have Sold Stock Recently Over the last three months, we’ve seen significant insider selling at Intervacc. In total, Chief Scientific Officer Jan-Ingmar Flock dumped kr730k worth of shares in that time, and we didn’t record any purchases whatsoever. Dozens of bullish and bearish live candlestick chart patterns for the Intervacc AB stock.